European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading

MT Newswires Live04-07

European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, as they were down 0.67% to 1,745.91 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by petroleum refiner Equinor (EQNR) and 3D printer company Materialise (MTLS), which advanced 1.6% and 1.2% respectively. They were followed by biopharmaceutical company argenx (ARGX) and internet browser company Opera (OPRA), which increased 0.5% and 0.4% respectively.

The decliners from continental Europe were led by biotech firm BioNTech (BNTX) and pharmaceutical company Ascendis Pharma (ASND), which dropped 3% each. They were followed by biopharmaceutical companies Grifols (GRFS) and Cellectis (CLLS), which lost 2.9% each.

The gainers from the UK were led by communications company WPP (WPP) and telecommunications operator Vodafone Group (VOD), which rose 2.4% and 1.9% respectively. They were followed by educational publisher Pearson (PSO) and biopharmaceutical company NuCana (NCNA), which were up 1.4% and 1.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and pharmaceutical company Silence Therapeutics (SLN), which shed 14% and 4.6% respectively. They were followed by cruise line operator Carnival (CUK) and biotech firm Trinity Biotech (TRIB), which were down 3.2% and 3% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment